Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: Turner syndrome
CADTH
            Record ID 32014000804
            English
                                                            
                Authors' recommendations:
                Based on CDR calculations using a confidential price of $vvvvvv per mg, the daily cost of the maximum dose of Genotropin ($vvvvvv; 0.33 mg/kg/week) is less than that of Humatrope ($100; 0.375 mg/kg/week), Nutropin ($84; 0.375 mg/kg/week), and Saizen ($96; 0.320 to 0.375 mg/kg/week).
            
                                    
            Details
                        
                Project Status:
                Completed
            
                                                            
                Year Published:
                2014
            
                                    
                URL for published report:
                http://www.cadth.ca/media/cdr/pharmacoeconomic/SR0334_GenotropinTS_PE_Report_e.pdf
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Not Assigned
            
                                    
                Country:
                Canada
            
                                                
                        MeSH Terms
            - Humans
- Cost-Benefit Analysis
Contact
                        
                Organisation Name:
                Canadian Agency for Drugs and Technologies in Health
            
            
                        
                Contact Address:
                600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
            
                                    
                Contact Name:
                requests@cadth.ca
            
                                    
                Contact Email:
                requests@cadth.ca
            
                                    
                Copyright:
                Canadian Agency for Drugs and Technologies in Health (CADTH)
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.